# Etoposide in the First-line Treatment of Adult EBV-HLH

> **NCT03742115** · PHASE3 · UNKNOWN · sponsor: **Beijing Friendship Hospital** · enrollment: 90 (estimated)

## Conditions studied

- Hemophagocytic Lymphohistiocytosis

## Interventions

- **DRUG:** Etoposide
- **DRUG:** Dexamethasone
- **DRUG:** Etoposide
- **DRUG:** IVIG

## Key facts

- **NCT ID:** NCT03742115
- **Lead sponsor:** Beijing Friendship Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-12-01
- **Primary completion:** 2019-12-01
- **Final completion:** 2020-12-01
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2018-11-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03742115

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03742115, "Etoposide in the First-line Treatment of Adult EBV-HLH". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03742115. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*